Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Johnston

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
International Journal of Trauma Nursing|March 23, 1999
Youth Alternative Sentencing Program: a description and evaluation of an alcohol and marijuana intervention programD D Lynsky, B S Heischober, P M Johnston, et al.
Plos One|June 2, 2018
Synthetic vaccine particles for durable cytolytic T lymphocyte responses and anti-tumor immunotherapyPetr O Ilyinskii, Grigoriy I Kovalev, Conlin P O'Neil, et al.
Molecular Therapy. Methods & Clinical Development|September 6, 2021
ImmTOR nanoparticles enhance AAV transgene expression after initial and repeat dosing in a mouse model of methylmalonic acidemiaPetr O Ilyinskii, Alicia M Michaud, Gina L Rizzo, et al.
Vaccine|March 6, 2014
Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine releasePetr O Ilyinskii, Christopher J Roy, Conlin P O'Neil, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
International Journal of Trauma Nursing|March 23, 1999
Youth Alternative Sentencing Program: a description and evaluation of an alcohol and marijuana intervention programD D Lynsky, B S Heischober, P M Johnston, et al.
Plos One|June 2, 2018
Synthetic vaccine particles for durable cytolytic T lymphocyte responses and anti-tumor immunotherapyPetr O Ilyinskii, Grigoriy I Kovalev, Conlin P O'Neil, et al.
Molecular Therapy. Methods & Clinical Development|September 6, 2021
ImmTOR nanoparticles enhance AAV transgene expression after initial and repeat dosing in a mouse model of methylmalonic acidemiaPetr O Ilyinskii, Alicia M Michaud, Gina L Rizzo, et al.
Vaccine|March 6, 2014
Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine releasePetr O Ilyinskii, Christopher J Roy, Conlin P O'Neil, et al.
Pageof 2